EUVD-2023-55158

Malicious code in bioql PyPI...

CVE-2023-50357

A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users...

Cross site scripting

A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users...

CVE-2023-50357

The provided data describe CVE-2023-50357 as a cross-site scripting vulnerability in AREAL SAS Websrv1 ASP Web site. Affected component: AREAL SAS Websrv1 ASP Web site/websrv1 component. Root cause: XSS enabling an attacker to execute script in a victim’s session, with remote, low-privilege acces...

CVE-2023-50357: Improper Neutralization of Input During Web Page Generation

A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users...

AREAL Topkapi Cross-Site Scripting Vulnerability

AREAL Topkapi, a multi-sector solution from the French company AREAL, is an innovative software platform that provides functionality far beyond the traditional capabilities of SCADA software. AREAL Topkapi suffers from a cross-site scripting vulnerability that originates from the presence of a...

PT-2024-13924

Name of the Vulnerable Software and Affected Versions AREAL SAS Websrv1 ASP website affected versions not specified Description A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users...